Department of Medical and Surgical Gynecology, Mayo Clinic, Jacksonville, FL, United States of America.
Mayo Clinic Alix School of Medicine, Mayo Clinic, Scottsdale, AZ, United States of America.
Gynecol Oncol. 2022 Oct;167(1):81-88. doi: 10.1016/j.ygyno.2022.07.025. Epub 2022 Jul 29.
Endosalpingiosis is a poorly understood condition of ectopic epithelium resembling the fallopian tubes. It has been described as an incidental pathology finding, a disease similar to endometriosis, and in association with malignancy. The objective of this study is to determine if endosalpingiosis (ES) has an increased association with gynecologic malignancy when compared to endometriosis (EM).
This is a retrospective case-control analysis of patients with a histologic diagnosis of endosalpingiosis or endometriosis at three affiliated academic hospitals between 2000 and 2020. All ES patients were included, and 1:1 matching was attempted to obtain a comparable cohort of EM patients. Demographic and clinical data were obtained, and statistical analysis was performed.
A total of 967 patients (515 ES and 452 EM) were included. ES patients were significantly older than EM patients (median age 52 vs 48 years, p < 0.001). The ES group had significantly more cancer diagnoses at surgery than the EM group (40.1% vs 18.1%, p < 0.001); this difference persisted in a sub-analysis excluding patients with known or suspected malignancy (20.9% vs 5.6%, p < 0.001). ES patients had lower overall survival (10-year freedom from death: 77.0% vs 90.5%, p < 0.001). After adjusting for confounders, multivariable analysis showed that ES patients had increased cancer diagnosed at surgery (OR = 2.48, p < 0.001) and greater risk of death (OR = 1.69, p = 0.017).
Endosalpingiosis was found concurrently with malignancy in 40% of cases, and this effect was preserved in multi-variable and sub-group analyses. Further research consisting of longer follow-up and exploration of molecular relationships between ES and cancer are forthcoming.
内膜异位症是一种异位上皮类似于输卵管的疾病,其发病机制尚不清楚。它已被描述为偶然的病理学发现、类似于子宫内膜异位症的疾病,以及与恶性肿瘤相关。本研究的目的是确定与子宫内膜异位症(EM)相比,内膜异位症(ES)在妇科恶性肿瘤中的相关性是否增加。
这是对 2000 年至 2020 年间在三家学术附属医院进行组织学诊断为内膜异位症或内膜异位症的患者进行的回顾性病例对照分析。所有 ES 患者均被纳入,并且尝试进行 1:1 匹配以获得可比的 EM 患者队列。获取人口统计学和临床数据,并进行统计分析。
共纳入 967 例患者(515 例 ES 和 452 例 EM)。ES 患者明显比 EM 患者年龄大(中位年龄 52 岁 vs 48 岁,p < 0.001)。ES 组在手术中诊断出的癌症明显多于 EM 组(40.1% vs 18.1%,p < 0.001);在排除已知或疑似恶性肿瘤的患者的亚分析中,这一差异仍然存在(20.9% vs 5.6%,p < 0.001)。ES 患者的总体生存率较低(10 年无死亡自由:77.0% vs 90.5%,p < 0.001)。调整混杂因素后,多变量分析显示 ES 患者手术中诊断出的癌症增加(OR = 2.48,p < 0.001)和死亡风险增加(OR = 1.69,p = 0.017)。
内膜异位症在 40%的病例中与恶性肿瘤同时存在,并且这种影响在多变量和亚组分析中得到保留。正在进行进一步的研究,包括更长时间的随访和探索内膜异位症与癌症之间的分子关系。